Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.
Sevil Korkmaz-IcözBartosz SzczesnyMichela MarcattiShiliang LiMihály RuppertFelix LasitschkaSivakkanan LoganathanCsaba SzabóGábor SzabóPublished in: British journal of pharmacology (2017)
This article is part of a themed section on Inventing New Therapies Without Reinventing the Wheel: The Power of Drug Repurposing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.2/issuetoc.